Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Alterity, Antengene, Astrazeneca, Beigene, Biontech, Daiichi Sankyo, Direct Biologics, Gilead Sciences, Langsheng, Lemonex, Moderna, Molecular Partners, Novartis, Pfizer, Sorrento, Valneva.